ArticleFrontiers in immunology2026
Dual role of N4BP1 in neutrophil-epithelial crosstalk in periodontitis.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Periodontitis is a chronic inflammatory disease driven by immune dysregulation, in which neutrophils play a central but functionally heterogeneous role. The contributions of specific neutrophil subsets to disease pathogenesis remain poorly defined. Methods: We integrated single-cell RNA sequencing (scRNA-seq) and Mendelian randomization analysis to identify disease-associated immune cell subsets and gene regulatory mechanisms. Cell-type-specific interactions and pathway alterations were further analyzed to uncover potential pathogenic mediators. Key findings were validated using a murine ligature-induced periodontitis model, supplemented by targeted modulation of N4BP1 in primary human gingival epithelial cells and neutrophils. Results: We identified a transcriptionally defined neutrophil subset that resembles previously reported low-density neutrophils, which we provisionally designate as LDN-1. This subset is characterized by aberrant interactions with epithelial cells primarily mediated by dysregulation of N4BP1. N4BP1 exhibited a dual, cell-type-specific role: its downregulation in epithelial cells impaired mucosal barrier integrity, leading to increased inflammatory tissue damage. In LDN-1, N4BP1 exhibited a context-dependent regulatory function: it suppresses both pro-inflammatory CXCL1/6-CXCR1/2 signaling and anti-inflammatory ANXA1-FPR1/FPR2 pathways. This duality suggests that N4BP1 may calibrate the balance between pro- and anti-inflammatory signals during periodontitis progression. Conclusions: Our findings identify N4BP1 as a critical cell-type-specific molecular candidate that coordinates epithelial barrier function and neutrophil activity. Modulating N4BP1 or its downstream pathways may represent a potential precision therapeutic strategy for periodontitis and related inflammatory diseases, pending further interventional validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.